Current evidence on efficacy of COVID‐19 booster dose vaccination against the Omicron variant: A systematic review-Reference-Cited by-同舟云学术

Current evidence on efficacy of COVID‐19 booster dose vaccination against the Omicron variant: A systematic review

Published:2022-03-14 Issue:7 Volume:94 Page:2969-2976
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:Journal of Medical Virology

Author:

Chenchula Santenna¹,Karunakaran Padmavathi²,Sharma Sushil¹,Chavan Madhavrao¹

Affiliation:

1. Department of Pharmacology All India Institute of Medical Sciences (AIIMS) Mangalagiri Andhra Pradesh India

2. Department of Medicine SVS Medical College and Hospital Mahabubbnagar Telangana India

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.27697

Reference39 articles.

1. WHO. WHO Coronavirus (COVID‐19) Dashboard. Accessed December 05 2021.https://covid19.who.int/

2. WHO. Classification of Omicron (B.1.1.529): SARS‐CoV‐2 Variant of Concern. Accessed December 6 2021.https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern

3. European Centre for Disease Prevention and Control. Epidemiological Update. Omicron Variant of Concern—Data as of 16 December 2021. Accessed December 24 2021.https://www.ecdc.europa.eu/en/news-events/epidemiological-update-omicron-data-16-december

4. StedmanE. What are the symptoms of Omicron and has anyone died from it? Accessed December 4 2021.https://www.goodto.com/wellbeing/health/symptoms-omicron-variant-anyone-died-639120

5. European Centre for Disease Prevention and Control.2021. Implications of the emergence and spread of the SARS‐CoV‐2 B.1.1.529 variant of concern (Omicron) for the EU/EEA ECDC Stockholm.https://www.ecdc.europa.eu/en/publications-data/covid-19-threat-assessment-spread-omicron-first-update

Cited by 228 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of vaccinations and school restrictions on the spread of COVID-19 in different age groups in Germany;Infectious Disease Modelling;2024-12

2. COVID-19 real world data infrastructure: A big data resource for study of the impact of COVID-19 in patient populations with immunocompromising conditions;2024-09-09

3. Difference in the impact of coinfections and secondary infections on antibiotic use in patients hospitalized with COVID-19 between the Omicron-dominant period and the pre-Omicron period;Journal of Infection and Chemotherapy;2024-09

4. Antigen-specific T helper cells and cytokine profiles predict intensity and longevity of cellular and humoral responses to SARS-CoV-2 booster vaccination;Frontiers in Immunology;2024-08-29

5. Unlocking the puzzle: non-defining mutations in SARS-CoV-2 proteome may affect vaccine effectiveness;Frontiers in Public Health;2024-08-15